Health Condition 1: null- Patients planned for liver transplantation will be enrolled. Patients who have previously undergone liver transplantation and develop liver enzyme abnormalities.
Conditions
Interventions
None listed
Sponsors
Medanta The Medicity
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients attending the outpatient clinics or inpatient services of the hospital and being worked up for liver transplantation will be included. Patients who have undergone liver transplantation and return with liver injury (serum transaminase exceeding twice the upper limit of normal) will also be enrolled.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the frequency of HEV infection among liver transplant recipients who are receiving Immunosuppression, liver transplant recipients who return with liver enzyme elevation.Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the frequency of various HEV genotypes among above patients who are found to have HEV infection. To look for evidence of chronic HEV infection among above patient groups.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactYogesh Saini
Institute of liver transplantation and regenerative medicine,
Outcome results
None listed